These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28340945)

  • 1. Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.
    Rasmussen KL
    Atherosclerosis; 2016 Dec; 255():145-155. PubMed ID: 28340945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischemic heart disease: a review.
    Frikke-Schmidt R
    Scand J Clin Lab Invest Suppl; 2000; 233():3-25. PubMed ID: 11317940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population.
    Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
    Atherosclerosis; 2016 Mar; 246():63-70. PubMed ID: 26761769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of apolipoprotein E and risk of dementia in the general population.
    Rasmussen KL; Tybjaerg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
    Ann Neurol; 2015 Feb; 77(2):301-11. PubMed ID: 25469919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
    Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
    Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia.
    Koch M; DeKosky ST; Goodman M; Sun J; Furtado JD; Fitzpatrick AL; Mackey RH; Cai T; Lopez OL; Kuller LH; Mukamal KJ; Jensen MK
    JAMA Netw Open; 2020 Jul; 3(7):e209250. PubMed ID: 32648923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and lipid and lipoprotein levels in dementia.
    Wehr H; Parnowski T; Puzyński S; Bednarska-Makaruk M; Bisko M; Kotapka-Minc S; Rodo M; Wołkowska M
    Dement Geriatr Cogn Disord; 2000; 11(2):70-3. PubMed ID: 10705163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
    Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals.
    Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
    Alzheimers Dement; 2018 Jan; 14(1):71-80. PubMed ID: 28774656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients.
    Bednarska-Makaruk M; Rodo M; Graban A; Lojkowska W; Bochyńska A; Ryglewicz D; Wehr H
    J Neurol Sci; 2009 Aug; 283(1-2):137-8. PubMed ID: 19303604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.
    Güz G; Nurhan Ozdemir F; Sezer S; Işiklar I; Arat Z; Turan M; Haberal M
    Am J Kidney Dis; 2000 Oct; 36(4):826-36. PubMed ID: 11007687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
    Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
    Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype.
    Yasuno F; Tanimukai S; Sasaki M; Hidaka S; Ikejima C; Yamashita F; Kodama C; Mizukami K; Michikawa M; Asada T
    Am J Geriatr Psychiatry; 2012 Jul; 20(7):574-83. PubMed ID: 21407046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.
    Akram A; Schmeidler J; Katsel P; Hof PR; Haroutunian V
    Neurobiol Aging; 2012 Mar; 33(3):628.e1-628.e14. PubMed ID: 21676498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease.
    Ji Y; Urakami K; Adachi Y; Maeda M; Isoe K; Nakashima K
    Dement Geriatr Cogn Disord; 1998; 9(5):243-5. PubMed ID: 9701675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study.
    Grönroos P; Raitakari OT; Kähönen M; Hutri-Kähönen N; Marniemi J; Viikari J; Lehtimäki T
    Clin Chem Lab Med; 2007; 45(5):592-8. PubMed ID: 17484618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid metabolism in cognitive decline and dementia.
    Panza F; D'Introno A; Colacicco AM; Capurso C; Pichichero G; Capurso SA; Capurso A; Solfrizzi V
    Brain Res Rev; 2006 Aug; 51(2):275-92. PubMed ID: 16410024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
    Dufouil C; Richard F; Fiévet N; Dartigues JF; Ritchie K; Tzourio C; Amouyel P; Alpérovitch A
    Neurology; 2005 May; 64(9):1531-8. PubMed ID: 15883313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.